We spoke to the president of AstraZeneca about the pharma giant’s plans to get back to growth after losing billions in sales to generic competition

UK-based pharma giant AstraZeneca has lost $12 billion in revenue in the past few years. That’s been in large part because of generic competition that’s…

Read More We spoke to the president of AstraZeneca about the pharma giant’s plans to get back to growth after losing billions in sales to generic competition